Condition

Coronary Artery Aneurysm clinical trials and research

As of November 12, 2026, Find a Trial lists 3 Coronary Artery Aneurysm clinical trials that are recruiting, in China. By phase: Phase 4 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.

Newest Coronary Artery Aneurysm clinical trials

StudyPhaseWhereStatusRegistered
Analyzing Rivaroxaban in Chinese Children with Kawasaki Disease — Shanghai, Shanghai Municipality Recruiting May 29, 2025
Optimizing Rivaroxaban Dosing for Children with Giant Coronary Aneurysms After Kawasaki Disease Phase 4 Shanghai, Shanghai Municipality Recruiting May 18, 2025
Rivaroxaban for children over 2 with giant coronary artery aneurysms after Kawasaki disease Phase 4 Shanghai, Shanghai Municipality Recruiting Dec 9, 2022

All recruiting trials (3)

Related topics

Kawasaki DiseaseRivaroxabanPharmacokinetics and PharmacodynamicsPilot Study

Quick answers

How many Coronary Artery Aneurysm clinical trials are recruiting right now?

3, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in China. Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 4: 2. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →

Last reviewed 2026-11-12 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.